Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients.

Autor: Mintchev ME; Hematology and Oncology Service, Brooke Army Medical Center, Fort Sam Houston, USA., Kalra AG; Internal Medicine Service, Brooke Army Medical Center, Fort Sam Houston, USA., Kou CJ; Hematology and Oncology Service, Brooke Army Medical Center, Fort Sam Houston, USA., Aden JK; Statistics, Brooke Army Medical Center, Fort Sam Houston, USA., Bezzant ML; Internal Medicine Service, Brooke Army Medical Center, Fort Sam Houston, USA., Dela Cruz WP; Hematology and Oncology Service, Brooke Army Medical Center, Fort Sam Houston, USA., Bersabe AR; Hematology/Oncology, Keesler Air Force Base Hospital, Biloxi, USA.

Publikováno v: Cureus [Cureus] 2022 Apr 25; Vol. 14 (4), pp. e24465. Date of Electronic Publication: 2022 Apr 25 (Print Publication: 2022).

A Non-Hereditary Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.

Autor: Kapila V; Internal Medicine, Central Michigan University College of Medicine, Mt. Pleasant, USA., Kalra AG; Internal Medicine, Brooke Army Medical Center, San Antonio, USA., Stockman DL; Pathology, OrthoPath Labs, Kalamazoo, USA.

Publikováno v: Cureus [Cureus] 2021 Feb 15; Vol. 13 (2), pp. e13344. Date of Electronic Publication: 2021 Feb 15.